Aurinia Pharmaceuticals's total assets for Q4 2024 were $550.64M, an increase of 0.23% from the previous quarter. GB:0UJF total liabilities were $173.17M for the fiscal quarter, a 7.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.